Response to Briggs by Manuel, John
Correspondence
association between [chronic PM] air pol-
lution exposure and health [mortality]." In
applying these criteria, I have included
experimental studies in animals and epi-
demiologic studies in humans (6). Rodents
exposed to high concentrations of diesel
exhaust for life did not show early or
increased mortality (6). The available epi-
demiologic studies (3-5) showed only
weak associations across a narrow exposure
range. The possible role of PM and lung
function in the Six Cities Study suggested
that there were differences in lung function
between cities, but no measurable effect
attributable to PM25' In the Seventh Day
Adventist Study (5), there appeared to be a
coherent relationship between PM and
self-reported symptoms, but not between
PM and mortality. However, the analyses
required to evaluate fully this PM-symp-
toms association were not reported.
Furthermore, short-term exposures and
hospital admissions may have little to no
relevance for mortality from chronic expo-
sure (6,11). Finally, individual-level mea-
surements ofan analogous/surrogate PM2,5
exposure from the same populations and
same cities provided a test of the internal
consistency and biological coherence ofthe
ambient PM25 associations. I know of no
other experimental or clinical human stud-
ies that can be used as a more appropriate
test.
I did not say or mean to imply that all
ofHill's (1) criteria must be obeyed before
accepting cause and effect. The only criteri-
on that must be met is that exposure must
precede the effect (6,12). I agree with
Loomis et al. that Hill's (1) guidelines can
be "helpful at the margins ofepidemiologic
interpretations" (as with PM), but also pro-
vide agood framework for assessing causali-
ty in general. I do not believe that evidence
was excluded, as alleged by Loomis et al.,
although further tests ofthe plausibility and
coherence of these associations with PM
maybe possible.
Regarding the use of Hertz-Picciotto's
criteria (2), my point was to assess whether
the EPAwas justified in developing quanti-
tative concentration-response information
useful in developing an annual PM2.5 stan-
dard from these studies. Table 5 in my
paper (6) was an attempt to do this;
because both studies were of the same
design, the criteria were applied to both the
design and the two individual studies. I
conduded (6) that
none ofthe Hertz-Picciotto criteria for quantifi-
cation of risk and setting air quality standards
using [these] epidemiology studies are met.
I believe these are useful guidelines and that
they do "contribute to a firmer scientific
foundation for low-dose risk estimates and
the ensuingregulatoryactions"(Z).
I suggest that the tobacco analogy analy-
sis provides evidence "that a given type of
bias did ... occur" and that it did "quantify
its direction and magnitude,"as stated by
Loomis et al., within the limits of the data
available. It was only possible to suggest
possible sources ofbias. The magnitude of
the confounding could not be calculated as
suggested by Loomis et al. for several rea-
sons. The univariate distributions were not
provided in the reports ofthese studies. The
bivariate distributions based on individual-
level data cannot be determined (8) because
the exposure variable is based on aggregate
data. Sensitivity analyses are valuable, but I
suggest that the tobacco analogy provides a
useful and fundamentally sound method for
what Loomis et al. describe as "quantitative
exploration ofpotential biases."
I suggest that one cannot be sure, with
any degree of certainty, that studies using
group-level measures of exposure are free
from the potential biases afflicting com-
pletely ecological designs. This is an area
where research using individual-level data
is needed to improve the quality of infor-
mation used to guide regulatory decisions.
John Gamble
Exxon Biomedical Sciences, Inc.
East Millstone, NewJersey
E-mail:jfgambl@fple.erenj.com
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"DoubleExposure": How Real
Is It?
The Focus artide "Double Exposure" [EHP
107:A196-A201 (1999)] is, for the most
part, nothing more than the continued
complaining ofthose who don't realize that
living is a hazard. They would place a risk
on everything and then ignore those they
don't like. I would like to challenge Manuel
to provide a laboratory analysis from any
reliable source [the American Cancer
Society (ACS), etc.] that can identify even
half of the stated 4,500 components he
cites. The ACS stated that 2 2,000 compo-
nents were present in smoke, but when
asked to list them, they could not. The
California Air Resources Board cites < 50
components at current detectable levels.
Only the tars and benzo[a]pyrene have even
been proven harmful to rats, and this has
been in massive doses. As a retired chemical
engineer with an extensive background in
chromatography and mass spectrography, I
can say with certainty that if4,500 compo-
nents exist in tobacco smoke, then the dean
air we breathe must contain 6,000 or more.
At 66 years ofage and a smoker ofover two
packs ofcigarettes a day for 47 years, I was
recently rejected for a Veterans'
Administration lung health study because
my lungs were "too healthy." Three guesses
what theirstudyresultswill show.
Wflliam C. Brig
Chemical Engineer, retired
Concord, California
E-mail: mrbill2b@silcon.com
Response to Briggs
The figure ofmore than 4,500 compounds
in tobacco smoke was obtained from an
article titled "Assessment of Exposure to
Environmental Tobacco Smoke" (1). The
U.S. Environmental Protection Agency (2)
cites a figure of "more than 4,000 com-
pounds" in its 1992 report. A table ofmany
of the constituents is listed on pages 3-5
through 3-9 ofthat report.
JohnManuel
Durham, North Carolina
E-mail: JManuel782@aol.com
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Environmental Tobacco
Smoke Epidemiology
The Focus article "Double Exposure"
[EHP 107:A196-A201 (1999)] mistakenly
reported that a meta-analysis ofepidemiol-
ogy studies examining the relationship
between exposure to environmental tobac-
co smoke (ETS) and human cancer was
prepared for the review of ETS in consid-
eration for listing in the National
Toxicology Program (NTP) Report on
Carcinogens. We would like to point out
that the results of several published meta-
analyses were considered during the ETS
review, but that the NTP did not, in fact,
perform an additional meta-analysis of
these data.
John R. Bucher
C.W.Jameson
NIEHS
Research Triangle Park, North Carolina
E-mail: bucher@niehs.nih.gov
Paraoxonase/MCS
Work in multiple laboratories on paraox-
onase polymorphism has shown that this
mammal enzyme protects against chlor-
pyrifos and other organophosphates differ-
entially, depending on which inherited
forms of the enzyme predominate. This
variable ability to process pesticides exists
in humans and is trackable ethnically (1),
and very recent articles have suggested the
polymorphism may be responsible for host
susceptibility to GulfWar syndrome (2,3).
Because my own interest is in multiple
chemical sensitivity (MCS) mechanisms, I
immediately searched Medline (National
Library of Medicine, Bethesda, MD) for
publications that included paraoxonase
and MCS, fibromyalgia, or chronic fatigue
syndrome (CFS), which have been suggest-
ed as being overlapping or identical with
each other and with Gulf War syndrome
(4,5). I found no other references at all.
I believe that there is a significant pos-
sibility that paraoxonase is important in
these conditions. A meta-model generating
six examples of MCS mechanisms that
could arise during situations of chemical
damage or rapid contextual change has
previously been shown (6). The first of
these models, and apparently the most
likely on the basis of existing clinical evi-
dence, is pesticide damage to the central
nervous system, in which exposures to
chlorpyrifos and other organophosphates
figure prominently in the supporting data.
In addition, another ofthe models explores
how host genetic variability in immune
response could lead, through conditioning,
to the heightened reactions to low levels of
other toxicants that is characteristic of
MCS, CFS, fibromyalgia (4), and Gulf
War syndrome (5). Both of these multiple
chemical sensitivity models could be satis-
fied simultaneously by the genetic varia-
tion of an enzyme that controls the ability
to resist damage from pesticides-an
enzyme such as paraoxonase.
This suggests that it may be worthwhile
to test statistically significant sizes ofMCS,
CFS, fibromyalgia, and GulfWar syndrome
patient populations to determine what
paraoxonase polymorphisms they carry. Ifit
were determined in any one ofthese popu-
lations that the condition is genetically
determined by reduced paraoxonase levels
or activity, this would solve the debate
about psychogenic or biogenic origins of
that condition. Additionally, it would allow
research funding to be confidently spent fol-
lowing up the mechanism, i.e., determining
exactly how the inability to process these
insecticides results in the condition.
A new study correlates significantly
lower frequency and activity of PON1-Q
paraoxonase polymorphism, which process-
es several organophosphates including some
nerve gases, with a symptomatic group of
GulfWar syndrome veterans, as compared
to well controls (7). This study has in effect
carried out my suggestion for one of the
groups, and its result strongly implies the
need to do the same for the others: MCS,
fibromyalgia, and CFS.
Steven C. Rowat
Grantham's Landing
British Columbia, Canada
E-mail: Steven_Rowat@sunshine.net
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